Lista de obras -

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

artículo científico publicado en 2014

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.

artículo científico

Aging and blood disorders: new perspectives, new challenges

artículo científico publicado en 2015

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

artículo científico publicado en 2017

Anemia at older age: etiologies, clinical implications and management

artículo científico publicado en 2017

Anemia in the elderly: clinical implications and new therapeutic concepts

artículo científico publicado en 2014

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

artículo científico publicado en 2017

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

artículo científico publicado en 2016

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

artículo científico publicado en 2014

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

artículo científico publicado en 2014

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group ⬇️

artículo científico publicado el 29 de abril de 2013

Cancer and ageism

artículo científico publicado en 2014

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

artículo científico publicado en 2017

Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype

artículo científico publicado en 2020

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System ⬇️

artículo científico publicado el 25 de abril de 2011

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia ⬇️

artículo científico publicado el 5 de enero de 2013

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients

artículo científico publicado en 2020

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

artículo científico publicado en 2017

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

artículo científico publicado en 2016

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

artículo científico publicado en 2007

Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group

artículo científico publicado en 2020

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

artículo científico publicado en 2013

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

scientific article published on 06 September 2018

Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.

artículo científico

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

artículo científico publicado en 2018

Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry

artículo científico publicado en 2014

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group

artículo científico publicado en 2015

Geriatric assessment of patients with hematological neoplasms

artículo científico publicado en 2017

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

artículo científico publicado en 2018

Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation

artículo científico publicado en 2002

Impact of age and comorbidity in myelodysplastic syndromes

artículo científico publicado en 2008

Individualized management and therapy of myelodysplastic syndromes

artículo científico publicado en 2008

Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia

artículo científico publicado en 2020

Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management

artículo científico publicado en 2015

Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.

artículo científico publicado en 2007

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge ⬇️

artículo científico publicado el 13 de febrero de 2012

Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis

artículo científico publicado en 2005

Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis

scientific article published on 27 January 2020

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

artículo científico publicado en 2017

Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort

artículo científico publicado en 2014

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

artículo científico publicado en 2014

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.

artículo científico publicado en 2018

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

artículo científico publicado en 2015

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

artículo científico publicado en 2017

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

artículo científico publicado en 2017

Revised international prognostic scoring system for myelodysplastic syndromes

artículo científico publicado en 2012

Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: A survey from Tyrolean hospitals ⬇️

artículo científico publicado el 13 de abril de 2011

Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.

artículo científico publicado en 2004

The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients

artículo científico publicado en 2012

Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha

artículo científico publicado en 2003

Time-dependent changes in mortality and transformation risk in MDS.

artículo científico publicado en 2016

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group

artículo científico publicado en 2014

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.

artículo científico publicado en 2015

Lista de obras de

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.

Aging and blood disorders: new perspectives, new challenges

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Anemia at older age: etiologies, clinical implications and management

Anemia in the elderly: clinical implications and new therapeutic concepts

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group ⬇️

Cancer and ageism

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System ⬇️

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia ⬇️

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group

Geriatric assessment of patients with hematological neoplasms

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation

Impact of age and comorbidity in myelodysplastic syndromes

Individualized management and therapy of myelodysplastic syndromes

Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia

Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management

Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge ⬇️

Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis

Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

Revised international prognostic scoring system for myelodysplastic syndromes

Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: A survey from Tyrolean hospitals ⬇️

Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.

The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients

Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha

Time-dependent changes in mortality and transformation risk in MDS.

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.